U.S. House | This week, the House Oversight and Accountability Committee held a hearing on “Oversight and Reauthorization of the Office of National Drug Control Policy." Dr. Rahul Gupta, ONDCP Director, testified regarding the critical services and initiatives delivered by ONDCP, illicit drug trafficking into the U.S., and the magnitude of drug overdose deaths as of late. ONDCP was last reauthorized in October 2018 through the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) and expires on September 30, 2023. Cont.
- Ann Tucker